Biolaser ApS: Financial statements 2020
CVR: 21333271
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Biolaser ApS (CVR 21333271) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -10,383 and a net result of DKK -169,120 compared with DKK 316,221 the year before. Equity in the 2020 report amounted to DKK 1,019,305. The solvency ratio was 75.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -10,383
- Profit/Loss
- DKK -169,120
- Equity
- DKK 1,019,305
- Total Assets
- DKK 1,353,072
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -10 t. | -169 t. | 1 mio. | 1 |
| 2019 | - | 593 t. | 316 t. | 1.2 mio. | 1 |
| 2018 | - | 288 t. | 223 t. | 872 t. | 0 |
| 2017 | - | 119 t. | 92 t. | 649 t. | - |
| 2016 | - | 456 t. | 356 t. | 557 t. | - |
How creditworthy is Biolaser ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Biolaser ApS has published its annual report for 2019. Gross profit came to DKK 593,328, and the net result was DKK 316,221.
About Biolaser ApS
Biolaser ApS is a Danish company of the type Anpartsselskab based in Fjerritslev, founded in 1998. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Caitanya Candradasa. The company is owned by Caitanya Candradasa. In 2025, the company reported a gross profit of DKK -133,181 and a net result of DKK -141,615 compared with DKK 82,521 the year before. Equity in the 2025 report amounted to DKK 685,450.